Pathstone Holdings
TMO icon

Pathstone Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Pathstone Holdings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8M Buy
73,043
+2,846
+4% +$1.37M 0.11% 131
2026
Q1 		$34.5M Sell
70,197
-7,944
-10% -$4.31M 0.14% 113
2025
Q4 		$45.3M Buy
78,141
+16,698
+27% +$9.44M 0.17% 79
2025
Q3 		$29.8M Buy
61,443
+1,651
+3% +$768K 0.11% 120
2025
Q2 		$24.3M Sell
59,792
-6,343
-10% -$2.65M 0.1% 141
2025
Q1 		$32.9M Sell
66,135
-3,257
-5% -$1.76M 0.14% 109
2024
Q4 		$36.1M Sell
69,392
-6,164
-8% -$3.39M 0.16% 86
2024
Q3 		$46.7M Buy
75,556
+8,408
+13% +$4.98M 0.21% 83
2024
Q2 		$37.1M Sell
67,148
-3,591
-5% -$2.06M 0.17% 92
2024
Q1 		$41.1M Buy
70,739
+13,526
+24% +$7.59M 0.19% 80
2023
Q4 		$30.4M Buy
+57,213
New +$27.7M 0.16% 95

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pathstone Holdings's TMO Position: Q2 2026 in Review

Pathstone Holdings increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q2 2026, buying an estimated $1.37M and bringing the position to 73,043 shares worth $36.8M. The position accounts for 0.11% of the portfolio, ranked #131.

Pathstone Holdings first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.7M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pathstone Holdings held 73,043 shares of Thermo Fisher Scientific worth $36.8M as of Q2 2026.
  • Pathstone Holdings bought 2,846 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.37M.
  • Thermo Fisher Scientific made up 0.11% of Pathstone Holdings's portfolio in Q2 2026, its #131 holding.
  • Pathstone Holdings first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Thermo Fisher Scientific position peaked at $46.7M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.